Show simple item record

dc.contributor.authorMorriss, Richard K.
dc.contributor.authorBenjamin, Benson
dc.date.accessioned2017-08-24T14:31:18Z
dc.date.available2017-08-24T14:31:18Z
dc.date.issued2008
dc.identifier.citationMorriss, R. K. & Benjamin, B. (2008). Lithium and eGFR: A new routinely available tool for the prevention of chronic kidney disease. The British Journal of Psychiatry, 193(2), pp.93-95.
dc.identifier.other10.1192/bjp.bp.108.051268
dc.identifier.urihttps://repository.nottinghamshirehealthcare.nhs.uk/handle/123456789/248
dc.description.abstractThe National Strategic Framework for Renal Services introduced the routine reporting of estimated glomerular filtration rates (eGFR) on serum urea and electrolyte tests. Estimated glomerular filtration rates might reduce renal failure induced by lithium and cardiovascular mortality but there are many false positives. We propose how eGFR might be used in lithium monitoring.
dc.description.urihttps://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/lithium-and-egfr-a-new-routinely-available-tool-for-the-prevention-of-chronic-kidney-disease/EE794969BCF2D9C860F67BFA9D696197
dc.subjectRenal insufficiency
dc.subjectDrug therapy
dc.titleLithium and eGFR: A new routinely available tool for the prevention of chronic kidney disease
dc.typeArticle


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record